ACM
AGIO icon

Aquatic Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Aquatic Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
38,627
+27,305
+241% +$828K 0.05% 462
2026
Q1 		$383K Sell
11,322
-24,684
-69% -$700K 0.01% 832
2025
Q4 		$980K Buy
+36,006
New +$1.26M 0.03% 555
2025
Q1 		– Sell
-529
Closed -$17.4K – 1232
2024
Q4 		$17.4K Buy
+529
New +$24.9K ﹤0.01% 1240
2024
Q3 		– Sell
-8,800
Closed -$379K – 1119
2024
Q2 		$379K Buy
+8,800
New +$318K 0.01% 602
2023
Q2 		– Sell
-1,100
Closed -$25K – 1288
2023
Q1 		$25K Buy
+1,100
New +$29.2K ﹤0.01% 1011
2022
Q2 		– Sell
-200
Closed -$6K – 1155
2022
Q1 		$6K Buy
+200
New +$6.11K 0.01% 777

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Aquatic Capital Management's AGIO Position: Q2 2026 in Review

Aquatic Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 241% in Q2 2026, buying an estimated $828K and bringing the position to 38,627 shares worth $1.43M. The position accounts for 0.05% of the portfolio, ranked #462.

Aquatic Capital Management first reported a position in AGIO in Q1 2022 and has held it in 7 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Aquatic Capital Management held 38,627 shares of Agios Pharmaceuticals worth $1.43M as of Q2 2026.
  • Aquatic Capital Management bought 27,305 Agios Pharmaceuticals shares in Q2 2026, an estimated $828K.
  • Agios Pharmaceuticals made up 0.05% of Aquatic Capital Management's portfolio in Q2 2026, its #462 holding.
  • Aquatic Capital Management first reported a position in Agios Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.